First Quarter 2018 Investor Presentation
Investor Presentation
First three months of 2018
The GLP-1 segment accounts for 12% of the global
diabetes care market value
Slide 60
Global GLP-1 market
GLP-1 value
in bDKK
VictozaⓇ
exenatide
dulaglutide
Ozempic®
other
Share of total
diabetes care
market
market
GLP-1 value and patient share of the total
diabetes care market
Share of total
diabetes care
GLP-1 value share of total diabetes
GLP-1 patient share¹ of total diabetes
70
10%
20%
60
8%
15%
CAGR value¹: 34.0%
15%
50
12%
6%
11%
40
10%
30
4%
7%
5%
20
5%
5%
5%
2%
3%
10
1%
0
0%
0%
Feb
2013
Feb
2018
World North Reg
America EU
Reg Reg Reg Reg
AAMEO J&K LATAM China
1 CAGR for 5-year period
Source: IQVIA monthly MAT Feb, 2018 value figures (DKK)
changing
diabetes®
Reg: Region; AAMEO: Africa, Asia, Middle-East and Oceania; J&K: Japan & Korea; LATAM: Latin America.
1 Patient share is indicative and based on data for US, UK, Germany and France only.
Source: Value data; IQVIA monthly MAT Feb, 2018. Patient data; IQVIA Disease Analyser (DE, FR, UK),
QuintilesIQVIA LRX (USA), Feb 2018View entire presentation